Sumitomo Mitsui Trust Group, Inc.
Position in BMRN — Biomarin Pharmaceutical Inc
CIK 1475365
CHIYODA-KU, TOKYO, M0
Position in BMRN
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$698,084
+$8,906 QoQ
Shares Held
12,200
0.0% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#307
of 561 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BMRN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Sumitomo Mitsui Trust Group, Inc. holds $1,307,870,799 across 36 Biotechnology names. BMRN ranks #28 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
611,907 | $303,952,564 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
282,199 | $175,962,364 | |
| 3 | TECH |
BIO-TECHNE Corp
|
2,067,324 | $146,056,440 | |
| 4 | BEAM |
Beam Therapeutics Inc.
|
3,455,043 | $118,577,075 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
325,379 | $97,948,840 | |
| 6 | CRSP |
CRISPR Therapeutics AG
|
1,720,734 | $93,848,832 | |
| 7 | RPRX |
Royalty Pharma plc
|
1,187,943 | $66,607,964 | |
| 8 | RVMD |
Revolution Medicines, Inc.
|
306,300 | $57,363,864 |
All Filings in BMRN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $698,084 | 12,200 | Shares | Defined | 2026-07-30 | |
| 2026-03-31 | $689,178 | 12,200 | Shares | Defined | 2026-04-30 | |
| 2025-12-31 | $695,331 | 11,700 | Shares | Defined | 2026-01-23 | |
| 2025-09-30 | $24,479,236 | 451,980 | Shares | Defined | 2025-10-27 | |
| 2025-06-30 | $27,050,956 | 492,104 | Shares | Defined | 2025-07-31 | |
| 2025-03-31 | $33,029,549 | 467,245 | Shares | Defined | 2025-04-25 | |
| 2024-12-31 | $30,895,926 | 470,043 | Shares | Defined | 2025-01-28 | |
| 2024-09-30 | $32,059,058 | 456,097 | Shares | Defined | 2024-11-05 | |
| 2024-06-30 | $35,851,915 | 435,466 | Shares | Defined | 2024-07-19 | |
| 2024-03-31 | $41,704,850 | 477,500 | Shares | Defined | 2024-04-19 | |
| 2023-12-31 | $46,435,486 | 481,596 | Shares | Defined | 2024-01-30 | |
| 2023-09-30 | $43,125,240 | 487,401 | Shares | Defined | 2023-10-30 | |
| 2023-06-30 | $43,472,013 | 501,523 | Shares | Defined | 2023-07-31 | |
| 2023-03-31 | $56,778,436 | 583,900 | Shares | Defined | 2023-04-27 | |
| 2022-12-31 | $60,667,907 | 586,220 | Shares | Defined | 2023-01-30 | |
| 2022-09-30 | $50,242,500 | 592,692 | Shares | Defined | 2022-10-21 | |
| 2022-06-30 | $48,834,047 | 589,285 | Shares | Defined | 2022-07-26 | |
| 2022-03-31 | $43,483,706 | 563,991 | Shares | Defined | 2022-04-27 | |
| 2021-12-31 | $49,801,393 | 563,683 | Shares | Defined | 2022-02-02 | |
| 2021-09-30 | $40,914,157 | 529,359 | Shares | Defined | 2021-10-25 | |
| 2021-06-30 | $45,963,424 | 550,856 | Shares | Defined | 2021-08-02 | |
| 2021-03-31 | $44,274,910 | 586,345 | Shares | Defined | 2021-04-30 | |
| 2020-12-31 | $54,098,504 | 616,929 | Shares | Defined | 2021-02-05 | |
| 2020-09-30 | $73,084,502 | 960,627 | Shares | Defined | 2020-10-30 | |
| 2020-06-30 | $88,631,137 | 718,592 | Shares | Defined | 2020-07-27 | |
| 2020-03-31 | $60,361,307 | 714,335 | Shares | Defined | 2020-04-27 | |
| No filing history on record for this holder in this stock. | ||||||